{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:29:08Z","timestamp":1791325748811,"version":"4.3.1"},"reference-count":63,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2007,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            The diagnostic accuracy of an indirect immunofluorescence antibody test (IFAT) for\n            <jats:italic>Strongyloides stercoralis<\/jats:italic>\n            at different serum antibody titers was evaluated. To assess diagnostic sensitivity, sera from 156 patients with known strongyloidiasis were collected. Negative control sera were obtained from a composite group of 427 subjects (blood donors and hospitalized patients). With an area under the receiver-operating characteristic plot of 0.98, the IFAT showed a high level of diagnostic accuracy for strongyloidiasis. An antibody titer of \u22651:20, with 97% sensitivity and 98% specificity, was identified as the diagnostic threshold with the best overall performance. Cross-reactions were evaluated with 41 additional samples from patients with other known helminth infections, and the IFAT detected low-titer positivity in only one subject with filariasis. A positive IFAT result at an antibody dilution of \u22651:80 was virtually 100% specific, with 71% sensitivity. To test the usefulness of the IFAT as a monitoring tool, the changes in specific-antibody titers after treatment in a group of 155 patients were evaluated. Seroreversion or a decrease in antibody titer of twofold or more was observed in 60% of the patients. Response to treatment was directly correlated to the initial antibody titer, and a baseline titer of \u22651:80 was identified as the best predictor of response. In conclusion, a positive IFAT result at an antibody dilution of \u22651:20 is the optimal cutoff for screening. A titer of \u22651:80, with virtually no false-positive result, is a reliable cutoff for a serological assessment of treatment efficacy and for inclusion in clinical trials.\n          <\/jats:p>","DOI":"10.1128\/cvi.00278-06","type":"journal-article","created":{"date-parts":[[2006,11,30]],"date-time":"2006-11-30T02:04:55Z","timestamp":1164852295000},"page":"129-133","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":61,"title":["Evaluation of an Indirect Immunofluorescence Assay for Strongyloidiasis as a Tool for Diagnosis and Follow-Up"],"prefix":"10.1128","volume":"14","author":[{"given":"Marina","family":"Boscolo","sequence":"first","affiliation":[{"name":"Centre for Tropical Diseases, Sacro Cuore Hospital, Negrar, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gobbo","sequence":"additional","affiliation":[{"name":"Centre for Tropical Diseases, Sacro Cuore Hospital, Negrar, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Mantovani","sequence":"additional","affiliation":[{"name":"Medicine and Public Health Department, University of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Degani","sequence":"additional","affiliation":[{"name":"Centre for Tropical Diseases, Sacro Cuore Hospital, Negrar, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariella","family":"Anselmi","sequence":"additional","affiliation":[{"name":"Centre for Tropical Diseases, Sacro Cuore Hospital, Negrar, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldo Badona","family":"Monteiro","sequence":"additional","affiliation":[{"name":"Centre for Tropical Diseases, Sacro Cuore Hospital, Negrar, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Marocco","sequence":"additional","affiliation":[{"name":"Centre for Tropical Diseases, Sacro Cuore Hospital, Negrar, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Angheben","sequence":"additional","affiliation":[{"name":"Centre for Tropical Diseases, Sacro Cuore Hospital, Negrar, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Mistretta","sequence":"additional","affiliation":[{"name":"Centre for Tropical Diseases, Sacro Cuore Hospital, Negrar, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Santacatterina","sequence":"additional","affiliation":[{"name":"Centre for Tropical Diseases, Sacro Cuore Hospital, Negrar, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Tais","sequence":"additional","affiliation":[{"name":"Centre for Tropical Diseases, Sacro Cuore Hospital, Negrar, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeno","family":"Bisoffi","sequence":"additional","affiliation":[{"name":"Centre for Tropical Diseases, Sacro Cuore Hospital, Negrar, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","first-page":"152","volume":"3","unstructured":"Adams, M., W. Page, and R. Speare. 14 March 2003, posting date. Strongyloidiasis: an issue in Aboriginal communities. Rural Remote Health3:152. http:\/\/rrh.deakin.edu.au .","journal-title":"Rural Remote Health"},{"key":"e_1_3_1_3_2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.5897\/AJB2003.000-1093","volume":"2","year":"2003","unstructured":"Adenusi, A. A., A. O. Oke, and A. O. Adenusi. 2003. Comparison of ivermectin and thiabendazole in the treatment of uncomplicated human Strongyloides stercoralis infection. Afr. J. Biotechnol.2:465-469.","journal-title":"Afr. J. Biotechnol."},{"key":"e_1_3_1_4_2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jinf.2004.01.016","volume":"49","year":"2004","unstructured":"Alcaraz, C. O., R. I. Adell, P. S. Sanchez, M. J. Blasco, O. A. Sanchez, A. S. Aunon, and D. R. Calabuig. 2004. Characteristics and geographical profile of strongyloidiasis in healthcare area 11 of the Valencian community (Spain). J. Infect.49:152-158.","journal-title":"J. Infect."},{"key":"e_1_3_1_5_2","first-page":"402","volume":"7","year":"2003","unstructured":"Blatt, J. M., and G. A. Cantos. 2003. Evaluation of techniques for the diagnosis of Strongyloides stercoralis in human immunodeficiency virus (HIV) positive and HIV negative individuals in the city of Itajai, Brazil. Braz. J. Infect. Dis.7:402-408.","journal-title":"Braz. J. Infect. Dis."},{"key":"e_1_3_1_6_2","first-page":"87","year":"1987","unstructured":"Bour\u00e9e, P. 1987. Examens de laboratoire en m\u00e9decine tropicale, p. 87-88. Masson, Paris, France.","journal-title":"Examens de laboratoire en m\u00e9decine tropicale"},{"key":"e_1_3_1_7_2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(99)02744-0","volume":"355","year":"2000","unstructured":"Chiodini, P. L., A. J. C. Reid, M. J. Wiselka, R. Firmin, and J. Foweraker. 2000. Parenteral ivermectin in Strongyloides hyperinfection. Lancet355:43-44.","journal-title":"Lancet"},{"key":"e_1_3_1_8_2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/01.mcg.0000152779.68900.33","volume":"39","year":"2005","unstructured":"Concha, R., W. Harrington, Jr., and A. I. Rogers. 2005. Intestinal strongyloidiasis: recognition, management, and determinants of outcome. J. Clin. Gastroenterol.39:203-211.","journal-title":"J. Clin. Gastroenterol."},{"key":"e_1_3_1_9_2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0035-9203(95)90527-8","volume":"89","year":"1995","unstructured":"Conway, D. J., A. Hall, K. S. Anwar, M. L. Rahman, and D. A. P. Bundy. 1995. Household aggregation of Strongyloides stercoralis infection in Bangladesh. Trans. R. Soc. Trop. Med. Hyg.89:258-261.","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"e_1_3_1_10_2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0035-9203(93)90477-8","volume":"87","year":"1993","unstructured":"Conway, D. J., N. S. Atkins, J. E. Lillywhite, J. W. Bailey, R. D. Robinson, J. F. Lindo, D. A. P. Bundy, and A. E. Bianco. 1993. Immunodiagnosis of Strongyloides stercoralis infection: a method for increasing the specificity of the indirect ELISA. Trans. R. Soc. Trop. Med. Hyg.87:173-176.","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"e_1_3_1_11_2","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0035-9203(94)90110-4","volume":"88","year":"1994","unstructured":"Datry, A., I. Hilmarsdottir, R. Mayorga-Sagastume, M. Lyagoubi, P. Gavotte, S. Giligui, J. Chodakewitz, D. Neu, M. Danis, and M. Gentilizi. 1994. Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 cases. Trans. R. Soc. Trop. Med. Hyg.88:344-345.","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"e_1_3_1_12_2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2307\/3283519","volume":"79","year":"1993","unstructured":"De Kaminski, R. G. 1993. Evaluation of three methods for laboratory diagnosis of Strongyloides stercoralis infection. J. Parasitol.79:277-280.","journal-title":"J. Parasitol."},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.34.10.2569-2571.1996"},{"key":"e_1_3_1_14_2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4269\/ajtmh.1987.37.157","volume":"37","year":"1987","unstructured":"Gam, A. A., F. A. Neva, and W. A. Krotoski. 1987. Comparative sensitivity and specificity of ELISA and IHA for serodiagnosis of strongyloidiasis with larval antigens. Am. J. Trop. Med. Hyg.37:157-161.","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_1_15_2","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/infdis\/169.5.1076","volume":"169","year":"1994","unstructured":"Gann, P. H., F. A. Neva, and A. A. Gam. 1994. A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. J. Infect. Dis.169:1076-1079.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_16_2","unstructured":"Garcia L. S. and D. A. Bruckner. 1997. Diagnostic medical parasitology 3rd ed. p. 656-657. ASM Press Washington DC."},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.5.4.345"},{"key":"e_1_3_1_18_2","first-page":"391","volume":"89","year":"1987","unstructured":"Genta, R. M. 1987. Predictive value of an enzyme-linked immunosorbent assay (ELISA) for the serodiagnosis of strongyloidiasis. Am. J. Clin. Pathol.89:391-394.","journal-title":"Am. J. Clin. Pathol."},{"key":"e_1_3_1_19_2","first-page":"679","volume":"68","year":"1988","unstructured":"Genta, R. M., S. Gatti, M. J. Linke, C. Cevini, and M. Scaglia. 1988. Endemic strongyloidiasis in northern Italy: clinical and immunological aspects. Q. J. Med.68:679-690.","journal-title":"Q. J. Med."},{"key":"e_1_3_1_20_2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jama.1987.03400010053026","volume":"258","year":"1987","unstructured":"Genta, R. M., R. Weesner, R. W. Douce, T. Huitger-O'Connor, and P. D. Walzer. 1987. Strongyloidiasis in US veterans of the Vietnam and other wars. JAMA258:49-52.","journal-title":"JAMA"},{"key":"e_1_3_1_21_2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/qjmed\/hch133","volume":"97","year":"2004","unstructured":"Gill, G. V., E. Welch, J. W. Bailey, D. R. Bell, and N. J. Beeching. 2004. Chronic Strongyloides stercoralis infection in former British Far East prisoners of war. Q. J. Med.97:789-795.","journal-title":"Q. J. Med."},{"key":"e_1_3_1_22_2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0065-308X(08)60036-6","volume":"38","year":"1996","unstructured":"Grove, D. I. 1996. Human strongyloidiasis. Adv. Parasitol.38:251-309.","journal-title":"Adv. Parasitol."},{"key":"e_1_3_1_23_2","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4269\/ajtmh.1981.30.344","volume":"30","year":"1981","unstructured":"Grove, D. I., and A. J. Blair. 1981. Diagnosis of human strongyloidiasis by immunofluorescence, using Strongyloides ratti and S. stercoralis larvae. Am. J. Trop. Med. Hyg.30:344-349.","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_1_24_2","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1086\/421268","volume":"38","year":"2004","unstructured":"Gushulak, B. D., and D. W. MacPherson. 2004. Globalization of infectious diseases: the impact of migration. Clin. Infect. Dis.38:1742-1748.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_1_25_2","first-page":"809","volume":"110","year":"1986","unstructured":"Hakim, S. Z., and R. M. Genta. 1986. Fatal disseminated strongyloidiasis in a Vietnam war veteran. Arch. Pathol. Lab. Med.110:809-812.","journal-title":"Arch. Pathol. Lab. Med."},{"key":"e_1_3_1_26_2","first-page":"2615","volume":"12","year":"2004","unstructured":"Igual-Adell, R., C. Oltra-Alcaraz, E. Soler-Company, P. Sanchez-Sanchez, J. Matogo-Oyana, and D. Rodriguez-Calabuig. 2004. Efficacy and safety of ivermectin and thiabendazole in the treatment of strongyloidiasis. Expert Opin. Pharmacother.12:2615-2619.","journal-title":"Expert Opin. Pharmacother."},{"key":"e_1_3_1_27_2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1440-1584.2005.00710.x","volume":"13","year":"2005","unstructured":"Johnston, F. H., P. S. Morris, R. Speare, J. McCarthy, B. Currie, D. Ewald, W. Page, and K. Dempsey. 2005. Strongyloidiasis: a review of the evidence for Australian practitioners. Aust. J. Rural Health13:247-254.","journal-title":"Aust. J. Rural Health"},{"key":"e_1_3_1_28_2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0035-9203(99)90132-3","volume":"93","year":"1999","unstructured":"Jongwutiwes, S., M. Charoenkorn, P. Sitthichareonchai, P. Akaraborvorn, and C. Putaporntip. 1999. Increased sensitivity of routine laboratory detection of Strongyloides stercoralis and hookworm by agar-plate culture. Trans. R. Soc. Trop. Med. Hyg.93:398-400.","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"e_1_3_1_29_2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1708-8305.2006.00004.x","volume":"13","year":"2006","unstructured":"Karunajeewa, H., H. Kelly, D. Leslie, J. Leydon, P. Saykao, and B. A. Biggs. 2006. Parasite-specific IgG response and peripheral blood eosinophil count following albendazole treatment for presumed chronic strongyloidiasis. J. Travel Med.13:84-91.","journal-title":"J. Travel Med."},{"key":"e_1_3_1_30_2","first-page":"138","volume":"86","year":"1990","unstructured":"Kaslow, J. E., H. S. Novey, R. H. Zuch, and G. S. Spear. 1990. Disseminated strongyloidiasis: an unheralded risk of corticosteroid therapy. J. Allergy Clin. Immunol.86:138.","journal-title":"J. Allergy Clin. Immunol."},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.17.1.208-217.2004"},{"key":"e_1_3_1_32_2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1136\/bmj.324.7335.477","volume":"324","year":"2002","unstructured":"Knottnerus, J. A., C. van Weel, and J. W. Muris. 2002. Evaluation of diagnostic procedures. BMJ324:477-480.","journal-title":"BMJ"},{"key":"e_1_3_1_33_2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0732-8893(94)90129-5","volume":"18","year":"1994","unstructured":"Kobayashi, J., Y. Sato, H. Toma, and Y. Shiroma. 1994. Application of enzyme immunoassay for postchemotherapy evaluation of human strongyloidiasis. Diagn. Microbiol. Infect. Dis.18:19-23.","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"e_1_3_1_34_2","first-page":"214","volume":"23","year":"2004","unstructured":"Koosha, S., M. Fesharaki, and M. B. Rokni. 2004. Comparison of enzyme-linked immunosorbent assay and indirect immunofluorescence assay in the diagnosis of human strongyloidiasis. Indian J. Gastroenterol.23:214-216.","journal-title":"Indian J. Gastroenterol."},{"key":"e_1_3_1_35_2","first-page":"87","volume":"7","year":"2003","unstructured":"Lemos, L. B., Q. Zhenhong, R. Laucirica, and H. L. Fred. 2003. Hyperinfection syndrome in strongyloidiasis: report of two cases. Ann. Diagn. Pathol.7:87-94.","journal-title":"Ann. Diagn. Pathol."},{"key":"e_1_3_1_36_2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1503\/cmaj.1031698","volume":"171","year":"2004","unstructured":"Lim, S., K. Katz, S. Krajden, M. Fuksa, J. S. Keystone, and K. C. Kain. 2004. Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management. Can. J. Med. Assoc.171:479-484.","journal-title":"Can. J. Med. Assoc."},{"key":"e_1_3_1_37_2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4269\/ajtmh.1994.51.175","volume":"51","year":"1994","unstructured":"Lindo, J. F., D. J. Conway, N. S. Atkins, A. E. Bianco, R. D. Robinson, and D. A. P. Bundy. 1994. Prospective evaluation of enzyme-linked immunosorbent assay and immunoblot methods for the diagnosis of endemic Strongyloides stercoralis infection. Am. J. Trop. Med. Hyg.51:175-179.","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_1_38_2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0035-9203(96)90444-7","volume":"90","year":"1996","unstructured":"Lindo, J. F., N. S. Atkins, M. G. Lee, R. D. Robinson, and A. P. Bundy. 1996. Parasite-specific serum IgG following successful treatment of endemic strongyloidiasis using ivermectin. Trans. R. Soc. Trop. Med. Hyg.90:702-703.","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"e_1_3_1_39_2","doi-asserted-by":"crossref","first-page":"749","DOI":"10.4269\/ajtmh.2002.66.749","volume":"66","year":"2002","unstructured":"Loutfy, M. R., M. Wilson, J. S. Keystone, and K. C. Kain. 2002. Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. Am. J. Trop. Med. Hyg.66:749-752.","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_1_40_2","first-page":"179","volume":"16","year":"1999","unstructured":"Magnaval, J. F., J. M. Mansuy, L. Villeneuve, and S. Cassaing. 1999. A retrospective study of autochthonous strongyloidiasis in R\u00e9gion Midi-Pyr\u00e9n\u00e9es (southwestern France). Eur. J. Epidemiol.16:179-182.","journal-title":"Eur. J. Epidemiol."},{"key":"e_1_3_1_41_2","first-page":"88","volume":"22","year":"1991","unstructured":"Mangali, A., W. Chaicumpa, P. Nontasut, P. Chantavanij, P. Tapchaisri, and C. Viravan. 1991. Enzyme-linked immunosorbent assay for diagnosis of human strongyloidiasis. Southeast Asian J. Trop. Med. Public Health22:88-92.","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"e_1_3_1_42_2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4269\/ajtmh.1996.55.477","volume":"55","year":"1996","unstructured":"Marti, H., H. J. Haji, L. Savioli, H. M. Chwaya, A. F. Mgeni, J. S. Ameir, and C. Hatz. 1996. A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children. Am. J. Trop. Med. Hyg.55:477-481.","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_1_43_2","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1056\/NEJM199903113401006","volume":"340","year":"1999","unstructured":"Muennig, P., D. Pallin, R. L. Sell, and M. S. Chan. 1999. The cost-effectiveness of strategies for the treatment of intestinal parasites in immigrants. N. Engl. J. Med.340:773-779.","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_1_44_2","first-page":"80","volume":"12","year":"2005","unstructured":"Nuesch, R., L. Zimmerli, R. Stockli, N. Gyr, and C. Hatz. 2005. Imported strongyloidosis: a longitudinal analysis of 31 cases. J. Travel Med.12:80-84.","journal-title":"J. Travel Med."},{"key":"e_1_3_1_45_2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ejim.2004.10.002","volume":"15","year":"2004","unstructured":"Olmos, J. M., S. Gracia, F. Villoria, R. Salesa, and J. Gonzalez-Macias. 2004. Disseminated strongyloidiasis in a patient with acquired immunodeficiency syndrome. Eur. J. Int. Med.15:529-530.","journal-title":"Eur. J. Int. Med."},{"key":"e_1_3_1_46_2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4269\/ajtmh.2005.73.122","volume":"73","year":"2005","unstructured":"Pacanowski, J., M. Dos Santos, A. Roux, C. Le Maignan, J. Guillot, V. Lavarde, and M. Cornet. 2005. Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report. Am. J. Trop. Med. Hyg.73:122-124.","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_1_47_2","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.trstmh.2005.12.006","volume":"100","year":"2006","unstructured":"Page, W. A., K. Dempsey, and J. S. McCarthy. 2006. Utility of serological follow-up of chronic strongyloidiasis after anthelminthic chemotherapy. Trans. R. Soc. Trop. Med. Hyg.100:1056-1062.","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"e_1_3_1_48_2","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1469-0691.2006.01500.x","volume":"12","year":"2006","unstructured":"Pirisi, M., E. Salvador, Z. Bisoffi, M. Gobbo, C. Smirne, C. Gigli, R. Minisini, G. Fortina, G. Bellomo, and E. Bartoli. 2006. Unsuspected strongyloidiasis in hospitalized elderly patients with and without eosinophilia. Clin. Microbiol. Infect.12:787-792.","journal-title":"Clin. Microbiol. Infect."},{"key":"e_1_3_1_49_2","doi-asserted-by":"crossref","first-page":"336","DOI":"10.4269\/ajtmh.2003.69.336","volume":"69","year":"2003","unstructured":"Roman-Sanchez, P., A. Pastor-Guzman, S. Moreno-Guillem, R. Igual-Adell, S. Suner-Generoso, and C. Tornero-Estebanez. 2003. High prevalence of Strongyloides stercoralis among farm workers on the Mediterranean coast of Spain: analysis of the predictive factors of infection in developed countries. Am. J. Trop. Med. Hyg.69:336-340.","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_1_50_2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0732-8893(95)00247-2","volume":"23","year":"1995","unstructured":"Salazar, S. A., C. Gutierrez, and S. L. Berk. 1995. Value of the agar plate method for the diagnosis of intestinal strongyloidiasis. Diagn. Microbiol. Infect. Dis.23:141-145.","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"e_1_3_1_51_2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/qjmed\/94.7.357","volume":"94","year":"2001","unstructured":"Sanchez, P. R., A. P. Guzman, S. M. Guillen, R. I. Adell, A. M. Estruch, I. N. Ponzalo, and C. R. Olmos. 2001. Endemic strongyloidiasis on the Spanish Mediterranean coast. Q. J. Med.94:357-363.","journal-title":"Q. J. Med."},{"key":"e_1_3_1_52_2","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4269\/ajtmh.1995.53.248","volume":"53","year":"1995","unstructured":"Sato, Y., J. Kobayashi, and Y. Shiroma. 1995. Efficacy of stool examination for detection of Strongyloides infection. Am. J. Trop. Med. Hyg.53:248-250.","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_1_53_2","first-page":"328","volume":"77","year":"1984","unstructured":"Scaglia, M., R. Brustia, S. Gatti, A. M. Bernuzzi, M. Strosselli, A. Malfitano, and D. Capelli. 1984. Autochthonus strongyloidiasis in Italy: an epidemiological and cinical review of 150 cases. Bull. Soc. Pathol. Exot. Filiales77:328-332.","journal-title":"Bull. Soc. Pathol. Exot. Filiales"},{"key":"e_1_3_1_54_2","first-page":"417","year":"2006","unstructured":"Scaglia, M., S. Gatti, and E. G. Rondanelli. 2006. Strongiloidosi, p. 417-427. In M. Scaglia, S. Gatti, and E. G. Rondanelli (ed.), Parassiti e parassitosi umane. Dalla clinica al laboratorio. Selecta Medica, Pavia, Italy.","journal-title":"Parassiti e parassitosi umane"},{"key":"e_1_3_1_55_2","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1086\/314023","volume":"31","year":"2000","unstructured":"Schaffel, R., M. Nucci, R. Portugal, M. B. Castro, S. B. Ferriera, L. Almeida, N. Spector, and W. Pulcheri. 2000. Thiabendazole for the treatment of strongyloidiasis in patients with hematologic malignancies. Clin. Infect. Dis.31:821-822.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_1_56_2","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1086\/322707","volume":"33","year":"2001","unstructured":"Siddiqui, A. A., and S. L. Berk. 2001. Diagnosis of Strongyloides stercoralis infection. Clin. Infect. Dis.33:1040-1047.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_1_57_2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0035-9203(03)90069-1","volume":"97","year":"2003","unstructured":"Sithithaworn, P., T. Srisawangwong, S. Tesana, W. Daenseekaew, J. Sithithaworn, Y. Fujimaki, and K. Ando. 2003. Epidemiology of Strongyloides stercoralis in north-east Thailand: application of the agar plate culture technique compared with the enzyme-linked immunosorbent assay. Trans. R. Soc. Trop. Med. Hyg.97:398-402.","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"e_1_3_1_58_2","first-page":"264","volume":"4","unstructured":"Speare, R., and D. N. Durrheim. 8 October 2004, posting date. Strongyloides serology\u2014useful for diagnosis and management of strongyloidiasis in rural Indigenous populations, but important gaps in knowledge remain. Rural Remote Health4:264. http:\/\/rrh.deakin.edu.au .","journal-title":"Rural Remote Health"},{"key":"e_1_3_1_59_2","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1365-3156.2003.01069.x","volume":"8","year":"2003","unstructured":"Sudarshi, S., R. Stumpfle, M. Armstrong, T. Ellman, S. Parton, P. Krishnan, P. L. Chiodini, and C. J. M. Whitty. 2003. Clinical presentation and diagnostic sensitivity of laboratory tests for Strongyloides stercoralis in travellers compared with immigrants in a non-endemic country. Trop. Med. Int. Health8:728-732.","journal-title":"Trop. Med. Int. Health"},{"key":"e_1_3_1_60_2","doi-asserted-by":"crossref","first-page":"967","DOI":"10.4269\/ajtmh.1999.60.967","volume":"60","year":"1999","unstructured":"Uparanukraw, P., S. Phongsri, and N. Morakote. 1999. Fluctuations of larval excretion in Strongyloides stercoralis infection. Am. J. Trop. Med. Hyg.60:967-973.","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_1_61_2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4269\/ajtmh.2006.74.97","volume":"74","year":"2006","unstructured":"Yori, P. P., M. Kosek, R. H. Gilman, J. Cordova, C. Bern, C. B. Chavez, M. P. Olortegui, C. Montalvan, G. M. Sanchez, B. Worthen, J. Worthen, F. Leung, and C. V. Or\u00e9. 2006. Seroepidemiology of strongyloidiasis in the Peruvian Amazon. Am. J. Trop. Med. Hyg.74:97-102.","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_1_62_2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s101560200013","volume":"8","year":"2002","unstructured":"Zaha, O., T. Hirata, F. Kinjo, A. Saito, and H. Fukuhara. 2002. Efficacy of ivermectin for chronic strongyloidiasis: two single doses given 2 weeks apart. J. Infect. Chemother.8:94-98.","journal-title":"J. Infect. Chemother."},{"key":"e_1_3_1_63_2","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s10156-004-0345-Z","volume":"10","year":"2004","unstructured":"Zaha, O., T. Hirata, N. Uchima, F. Kinjo, and A. Saito. 2004. Comparison of anthelmintic effects of two doses of ivermectine on intestinal strongyloidiasis in patients negative or positive for anti-HTLV-1 antibody. J. Infect. Chemother.10:348-351.","journal-title":"J. Infect. Chemother."},{"key":"e_1_3_1_64_2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/clinchem\/39.4.561","volume":"39","year":"1993","unstructured":"Zweig, M. H., and G. Campbell. 1993. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem.39:561-577.","journal-title":"Clin. Chem."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00278-06","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00278-06","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T15:54:58Z","timestamp":1627574098000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00278-06"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["10.1128\/CVI.00278-06"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00278-06","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2]]},"assertion":[{"value":"2006-07-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2006-11-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}